(Q34648681)

3 August 2017

title

Estimation of the cost of MS in Europe: extrapolations from a multinational cost study (English)

1 reference

3 August 2017

Sobocki P

1

1 reference

3 August 2017

Pugliatti M

series ordinal

2

1 reference

3 August 2017

Lauer K

series ordinal

3

1 reference

3 August 2017

Kobelt G

series ordinal

4

1 reference

3 August 2017

publication date

10 July 2007

1 reference

Multiple Sclerosis Journal

3 August 2017

published in

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

issue

8

1 reference

3 August 2017

page(s)

1054-1064

1 reference

The epidemiology of multiple sclerosis in Europe.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

Economic evidence in multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

Costs and quality of life of patients with multiple sclerosis in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

Cost of disorders of the brain in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

Understanding quality-adjusted life years and their application to pharmacoeconomic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

Measurement of health state utilities for economic appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

Swedish population health-related quality of life results using the EQ-5D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

A comprehensive assessment of the cost of multiple sclerosis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

The economic cost of multiple sclerosis in Sweden in 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077941

21 January 2018

Identifiers

DOI

10.1177/1352458507077941

1 reference

3 August 2017

1 reference